Cargando…
GBA, Gaucher Disease, and Parkinson’s Disease: From Genetic to Clinic to New Therapeutic Approaches
Parkinson’s disease (PD) is the second most common degenerative disorder. Although the disease was described more than 200 years ago, its pathogenetic mechanisms have not yet been fully described. In recent years, the discovery of the association between mutations of the GBA gene (encoding for the l...
Autores principales: | Riboldi, Giulietta M., Di Fonzo, Alessio B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6523296/ https://www.ncbi.nlm.nih.gov/pubmed/31010158 http://dx.doi.org/10.3390/cells8040364 |
Ejemplares similares
-
Small Molecule Chaperones for the Treatment of Gaucher Disease and GBA1-Associated Parkinson Disease
por: Han, Tae-Un, et al.
Publicado: (2020) -
Transcriptome deregulation of peripheral monocytes and whole blood in GBA-related Parkinson’s disease
por: Riboldi, Giulietta Maria, et al.
Publicado: (2022) -
GBA1 variants in Brazilian Gaucher disease patients
por: Basgalupp, Suelen Porto, et al.
Publicado: (2023) -
A Practical Approach to Early-Onset Parkinsonism
por: Riboldi, Giulietta M., et al.
Publicado: (2022) -
Comprehensive short and long read sequencing analysis for the Gaucher and Parkinson’s disease-associated GBA gene
por: Toffoli, Marco, et al.
Publicado: (2022)